Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders is a clinical research site located in Pittsburgh, Pennsylvania, United States 15224.
Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.
Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Mucopolysaccharidosis Type II (MPS II), Mucopolysaccharidosis II.
Sponsors: REGENXBIO Inc..
Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has 3 clinical trials on record, with 1 currently active. Their work covers Mucopolysaccharidosis Type II (MPS II), Mucopolysaccharidosis II.
Children's Hospital of Pittsburgh - UPMC: Program for Neurodevelopment in Rare Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.